QMS Medical Allied Services Limited (NSE:QMSMEDI)
India
· Delayed Price · Currency is INR 90.00
-1.95 (-2.12%)
At close: May 19, 2025
NSE:QMSMEDI Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2018 - 2019 |
| Operating Revenue | 1,437 | 1,221 | 1,040 | 1,463 | 1,220 | 727.4 | Upgrade
|
| Other Revenue | - | - | - | 0.01 | - | - | Upgrade
|
| Revenue | 1,437 | 1,221 | 1,040 | 1,463 | 1,220 | 727.4 | Upgrade
|
| Revenue Growth (YoY) | 18.57% | 17.38% | -28.89% | 19.90% | 67.77% | 40.17% | Upgrade
|
| Cost of Revenue | 808.71 | 799.24 | 778.84 | 1,103 | 904.05 | 530.28 | Upgrade
|
| Gross Profit | 628.51 | 422.04 | 261.59 | 360.14 | 316.29 | 197.12 | Upgrade
|
| Selling, General & Admin | 100.14 | 67.88 | 55.18 | 46.66 | 28.31 | 19.18 | Upgrade
|
| Other Operating Expenses | 298.19 | 170.3 | 92.68 | 147.13 | 118.29 | 81.71 | Upgrade
|
| Operating Expenses | 431.83 | 272.58 | 158.59 | 205.41 | 153.95 | 104.47 | Upgrade
|
| Operating Income | 196.68 | 149.46 | 103 | 154.73 | 162.33 | 92.65 | Upgrade
|
| Interest Expense | -39.72 | -28.83 | -19.98 | -21.23 | -13.1 | -5.33 | Upgrade
|
| Interest & Investment Income | 4.56 | 4.56 | 6.23 | - | 0.03 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.4 | -0.4 | 0.7 | 0.74 | -0.2 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.43 | -2.43 | -2.9 | -3.19 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 161.56 | 122.36 | 87.05 | 131.05 | 149.06 | 87.21 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 13.51 | - | - | Upgrade
|
| Pretax Income | 161.56 | 122.36 | 87.05 | 144.56 | 149.06 | 87.21 | Upgrade
|
| Income Tax Expense | 45.25 | 32.33 | 23.27 | 37.7 | 39.89 | 23.67 | Upgrade
|
| Net Income | 102.89 | 90.02 | 63.78 | 106.86 | 109.18 | 63.54 | Upgrade
|
| Net Income to Common | 102.89 | 90.02 | 63.78 | 106.86 | 109.18 | 63.54 | Upgrade
|
| Net Income Growth | 13.91% | 41.14% | -40.31% | -2.12% | 71.83% | 109.29% | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 16 | 15 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 16 | 15 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | -0.02% | 9.05% | 8.76% | 33.33% | - | -25.00% | Upgrade
|
| EPS (Basic) | 5.76 | 5.04 | 3.90 | 7.10 | 9.67 | 5.63 | Upgrade
|
| EPS (Diluted) | 5.76 | 5.04 | 3.90 | 7.10 | 9.67 | 5.63 | Upgrade
|
| EPS Growth | 13.87% | 29.34% | -45.12% | -26.59% | 71.83% | 179.05% | Upgrade
|
| Free Cash Flow | - | -11.94 | -288.46 | -38.05 | -57.95 | -58.54 | Upgrade
|
| Free Cash Flow Per Share | - | -0.67 | -17.62 | -2.53 | -5.13 | -5.19 | Upgrade
|
| Dividend Per Share | - | 0.500 | 0.500 | - | - | - | Upgrade
|
| Gross Margin | 43.73% | 34.56% | 25.14% | 24.61% | 25.92% | 27.10% | Upgrade
|
| Operating Margin | 13.69% | 12.24% | 9.90% | 10.57% | 13.30% | 12.74% | Upgrade
|
| Profit Margin | 7.16% | 7.37% | 6.13% | 7.30% | 8.95% | 8.73% | Upgrade
|
| Free Cash Flow Margin | - | -0.98% | -27.73% | -2.60% | -4.75% | -8.05% | Upgrade
|
| EBITDA | 244.9 | 181.56 | 113.62 | 165.42 | 169.68 | 96.23 | Upgrade
|
| EBITDA Margin | 17.04% | 14.87% | 10.92% | 11.30% | 13.91% | 13.23% | Upgrade
|
| D&A For EBITDA | 48.21 | 32.1 | 10.62 | 10.69 | 7.35 | 3.58 | Upgrade
|
| EBIT | 196.68 | 149.46 | 103 | 154.73 | 162.33 | 92.65 | Upgrade
|
| EBIT Margin | 13.69% | 12.24% | 9.90% | 10.57% | 13.30% | 12.74% | Upgrade
|
| Effective Tax Rate | 28.01% | 26.43% | 26.73% | 26.08% | 26.76% | 27.15% | Upgrade
|
| Revenue as Reported | 1,445 | 1,226 | 1,048 | 1,477 | 1,221 | 727.78 | Upgrade
|
| Advertising Expenses | - | 9.98 | 10.23 | 0.88 | 0.43 | 0.24 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.